Korea Research Institute of Chemical Technology registered patent no. KR101332830B1 in 2012 (A Cancer sensitizer comprising phenylurea derivatives or salts thereof) which describes the development of phenyl urea derivatives as modulators of the tumor necrosis factor-related apoptosis (TRAIL) (Kim Seong, 2013). This evidence concerns the gene TNF and cancer.